{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T16:40:22Z","timestamp":1738600822339,"version":"3.35.0"},"posted":{"date-parts":[[2024,8,29]]},"group-title":"In Review","reference-count":33,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T00:00:00Z","timestamp":1724889600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,8,1]]},"abstract":"<title>Abstract<\/title>\n        <p><bold>Background<\/bold>\nRobust evidence suggests that the aberrant expression of \u03b1 defensin 5 protein (DEFA5) in colon inflammatory bowel diseases (IBDs) underlies the distinct pathogenesis of Crohn\u2019s colitis, can be exploited as a reliable diagnostic biomarker to differential diagnosis of Crohn\u2019s colitis (CC) from Ulcerative colitis (UC) in otherwise indeterminate colitis (IC). We evaluated the specificity of the commercially available anti-DEFA5 antibodies and showed further validation of their appropriateness for a given application is required.\n<bold>Methods<\/bold> We established two mouse monoclonal DEFA5 antibody clones 1A8 and 4F5 by immunizing the mice with purified recombinant protein and validated the specificity, selectivity and cross reactivity in recognizing the endogenous and recombinant DEFA5 protein, especially for Immunohistochemistry, Western blot, Immunoprecipitation, or enzyme-linked immunosorbent assay.\n<bold>Results<\/bold> Clones 1A8 and 4F5 recognized effectively the endogenous DEFA5 in active human diverticulitis (DV), UC, CC or IC disease samples, including transiently transfected HEK293T cells expressing DEFA5 with high degree of specificity and minimal non-confounding cross reactivity.\n<bold>Conclusions <\/bold>1A8 and 4F5 clones are worth studying in larger IBD cohorts to fully address whether DEFA5 expression may be used as a diagnostic biomarker to discrimination of the diagnosis of UC from CC or IC into authentic CC or UC or a colitis with different pathological characteristics.<\/p>","DOI":"10.21203\/rs.3.rs-4843765\/v1","type":"posted-content","created":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T09:09:19Z","timestamp":1724922559000},"source":"Crossref","is-referenced-by-count":0,"title":["Anti-DEFA5 Monoclonal Antibody Clones 1A8 and 4F5 Immunoreactive Bioassay for Diagnosing Inflammatory Bowel Disease"],"prefix":"10.21203","author":[{"given":"Rabi","family":"Thangaiyan","sequence":"first","affiliation":[{"name":"Meharry Medical College"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amos M.","family":"Sakwe","sequence":"additional","affiliation":[{"name":"Meharry Medical College"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander T.","family":"Hawkins","sequence":"additional","affiliation":[{"name":"Vanderbilt University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary K.","family":"Washington","sequence":"additional","affiliation":[{"name":"Vanderbilt University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Billy R.","family":"Ballard","sequence":"additional","affiliation":[{"name":"Meharry Medical College"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael G.","family":"Izban","sequence":"additional","affiliation":[{"name":"Meharry Medical College"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanika S.","family":"Chirwa","sequence":"additional","affiliation":[{"name":"Meharry Medical College"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James E.K.","family":"Hildreth","sequence":"additional","affiliation":[{"name":"Meharry Medical College"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anil","family":"Shanker","sequence":"additional","affiliation":[{"name":"Meharry Medical College"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David L.","family":"Blum","sequence":"additional","affiliation":[{"name":"University of Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amosy E.","family":"M'Koma","sequence":"additional","affiliation":[{"name":"Meharry Medical College"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"6","key":"ref1","first-page":"33","article-title":"Inflammatory Bowel Disease: An Expanding Global Health Problem","author":"M'Koma AE","year":"2013","unstructured":"M'Koma AE. Inflammatory Bowel Disease: An Expanding Global Health Problem. Clin Med Insights Gastroenterol 2013; (6): 33\u201347.","journal-title":"Clin Med Insights Gastroenterol"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/ibd.21349","article-title":"Epidemiology of pediatric inflammatory bowel disease: a systematic review of international trends","volume":"17","author":"Benchimol EI","year":"2011","unstructured":"Benchimol EI, Fortinsky KJ, Gozdyra P, Van den Heuvel M, Van LimbergenJ, Griffiths AM. Epidemiology of pediatric inflammatory bowel disease: a systematic review of international trends. Inflamm Bowel Dis. 2011;17(1):423\u201339.","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3390\/gidisord1010007","article-title":"The Multifactorial Etiopathogeneses Interplay of Inflammatory Bowel Disease: An Overview","volume":"1","author":"M'Koma AE","year":"2018","unstructured":"M'Koma AE. The Multifactorial Etiopathogeneses Interplay of Inflammatory Bowel Disease: An Overview. Gastrointest Disord. 2018;1(1):75\u2013105.","journal-title":"Gastrointest Disord"},{"issue":"9","key":"ref4","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/ng.3359","article-title":"Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations","volume":"47","author":"Liu JZ","year":"2015","unstructured":"Liu JZ, van Sommeren S, Huang H, Ng SC, Alberts R, Takahashi A, Ripke S, Lee JC, Jostins L, Shah T, Abedian S, Cheon JH, Cho J, Dayani NE, Franke L, Fuyuno Y, Hart A, Juyal RC, Juyal G, Kim WH, Morris AP, Poustchi H, Newman WG, Midha V, Orchard TR, Vahedi H, Sood A, Sung JY, Malekzadeh R, Westra HJ, Yamazaki K, Yang SK, Barrett JC, Alizadeh BZ, Parkes M, Bk T, Daly MJ, Kubo M, Anderson CA, Weersma RK. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat Genet. 2015;47(9):979\u201386. International Multiple Sclerosis Genetics, C, International I. B. D. G. C.","journal-title":"Nat Genet"},{"issue":"6","key":"ref5","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/gut.2005.082909","article-title":"The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications","volume":"55","author":"Satsangi J","year":"2006","unstructured":"Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55(6):749\u201353.","journal-title":"Gut"},{"issue":"41","key":"ref6","doi-asserted-by":"crossref","first-page":"15374","DOI":"10.3748\/wjg.v20.i41.15374","article-title":"Performance of the Montreal classification for inflammatory bowel diseases","volume":"20","author":"Spekhorst LM","year":"2014","unstructured":"Spekhorst LM, Visschedijk MC, Alberts R, Festen EA, van der Wouden EJ, Dijkstra G, Weersma RK, Dutch Initiative on C, Colitis. Performance of the Montreal classification for inflammatory bowel diseases. World J Gastroenterol. 2014;20(41):15374\u201381.","journal-title":"World J Gastroenterol"},{"issue":"8","key":"ref7","doi-asserted-by":"crossref","first-page":"e0179710","DOI":"10.1371\/journal.pone.0179710","article-title":"M'Koma A E. Human alpha defensin 5 is a candidate biomarker to delineate inflammatory bowel disease","volume":"12","author":"Williams AD","year":"2017","unstructured":"Williams AD, Korolkova OY, Sakwe AM, Geiger TM, James SD, Muldoon RL, Herline AJ, Goodwin JS, Izban MG, Washington MK, Smoot DT, Ballard BR, Gazouli M. M'Koma A E. Human alpha defensin 5 is a candidate biomarker to delineate inflammatory bowel disease. PLoS ONE. 2017;12(8):e0179710.","journal-title":"PLoS ONE"},{"issue":"3","key":"ref8","doi-asserted-by":"crossref","first-page":"e0246393","DOI":"10.1371\/journal.pone.0246393","article-title":"M'Koma A E. Linking bacterial enterotoxins and alpha defensin 5 expansion in the Crohn's colitis: A new insight into the etiopathogenetic and differentiation triggers driving colonic inflammatory bowel disease","volume":"16","author":"Rana T","year":"2021","unstructured":"Rana T, Korolkova OY, Rachakonda G, Williams AD, Hawkins AT, James SD, Sakwe AM, Hui N, Wang L, Yu C, Goodwin JS, Izban MG, Offodile RS, Washington MK, Ballard BR, Smoot DT, Shi XZ, Forbes DS, Shanker A. M'Koma A E. Linking bacterial enterotoxins and alpha defensin 5 expansion in the Crohn's colitis: A new insight into the etiopathogenetic and differentiation triggers driving colonic inflammatory bowel disease. PLoS ONE. 2021;16(3):e0246393.","journal-title":"PLoS ONE"},{"issue":"2","key":"ref9","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4103\/0022-3859.52846","article-title":"Declaration of Helsinki, 2008: implications for stakeholders in research","volume":"55","author":"Puri KS","year":"2009","unstructured":"Puri KS, Suresh KR, Gogtay NJ, Thatte UM. Declaration of Helsinki, 2008: implications for stakeholders in research. J Postgrad Med. 2009;55(2):131\u20134.","journal-title":"J Postgrad Med"},{"key":"ref10","first-page":"1","article-title":"Controversies between regulations of research ethics and protection of personal data: informed consent at a cross-road","volume":"17","author":"Gefenas E","year":"2021","unstructured":"Gefenas E. Controversies between regulations of research ethics and protection of personal data: informed consent at a cross-road. Med Health Care Philos. 2021;17:1\u20138.","journal-title":"Med Health Care Philos"},{"issue":"special issue","key":"ref11","first-page":"18","article-title":"Animal care and use committees: history and current policies in the United States","volume":"37","author":"Whitney RA","year":"1987","unstructured":"Whitney RA. Animal care and use committees: history and current policies in the United States. Lab Anim Sci. 1987;37(special issue):18\u201321.","journal-title":"Lab Anim Sci"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"21509","DOI":"10.1074\/jbc.M801851200","article-title":"The conserved salt bridge in human alpha-defensin 5 is required for its precursor processing and proteolytic stability","volume":"283","author":"Rajabi M","year":"2008","unstructured":"Rajabi M, de Leeuw E, Pazgier M, Li J, Lubkowski J, Lu W. The conserved salt bridge in human alpha-defensin 5 is required for its precursor processing and proteolytic stability. J Biol Chem. 2008;283:21509\u201318. 10.1074\/jbc.M801851200.","journal-title":"J Biol Chem"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/ni797","article-title":"Paneth cell trypsin is an enzyme that regulates human defensin-5","volume":"3","author":"Ghosh D","year":"2002","unstructured":"Ghosh D, Porter E, Shen B, Lee SK, Wilk D, Drazba J, Yadav SP, Crabb JW, Ganz T, Bevins CL. Paneth cell trypsin is an enzyme that regulates human defensin-5. Nat Immunol. 2002;3:583\u201390. 10.1038\/ni797.","journal-title":"Nat Immunol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"702","DOI":"10.2353\/ajpath.2008.070755","article-title":"Impaired luminal processing of human defensin-5 in Crohn's disease: persistence in a chymotrypsinogen and trypsin complex","volume":"172","author":"Elphick D","year":"2008","unstructured":"Elphick D, Liddell S, Mahida YR. Impaired luminal processing of human defensin-5 in Crohn's disease: persistence in a chymotrypsinogen and trypsin complex. Am J Pathol. 2008;172:702\u201313. 10.2353\/ajpath.2008.070755.","journal-title":"Am J Pathol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"23216","DOI":"10.1016\/S0021-9258(18)50079-X","article-title":"Paneth cells of the human small intestine express an antimicrobial peptide gene","volume":"267","author":"Jones DE","year":"1992","unstructured":"Jones DE, Bevins CL. Paneth cells of the human small intestine express an antimicrobial peptide gene. J Biol Chem. 1992;267:23216\u201325.","journal-title":"J Biol Chem"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0014-5793(93)81160-2","article-title":"Defensin-6 mRNA in human Paneth cells: implications forantimicrobial peptides in host defense of the human bowel","volume":"315","author":"Jones DE","year":"1993","unstructured":"Jones DE, Bevins CL. Defensin-6 mRNA in human Paneth cells: implications forantimicrobial peptides in host defense of the human bowel. FEBS Lett. 1993;315:187\u201392.","journal-title":"FEBS Lett"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1136\/gut.48.2.176","article-title":"Human defensin 5 is stored in precursor form in normal Paneth cells and is expressed by some villous epithelial cells and by metaplastic Paneth cells in the colon in inflammatory bowel disease","volume":"48","author":"Cunliffe RN","year":"2001","unstructured":"Cunliffe RN, Rose FR, Keyte J, et al. Human defensin 5 is stored in precursor form in normal Paneth cells and is expressed by some villous epithelial cells and by metaplastic Paneth cells in the colon in inflammatory bowel disease. Gut. 2001;48:176\u201385.","journal-title":"Gut"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0014-5793(98)00994-6","article-title":"Isolation of human intestinal defensins from ileal neobladder urine","volume":"434","author":"Porter EM","year":"1998","unstructured":"Porter EM, Poles MA, Lee JS, et al. Isolation of human intestinal defensins from ileal neobladder urine. FEBS Lett. 1998;434:272\u20136.","journal-title":"FEBS Lett"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1128\/iai.65.6.2389-2395.1997","article-title":"Localization of human intestinal defensin 5 in Paneth cell granules","volume":"65","author":"Porter EM","year":"1997","unstructured":"Porter EM, Liu L, Oren A, Anton PA, Ganz T. Localization of human intestinal defensin 5 in Paneth cell granules. Infect Immun. 1997;65:2389\u201395.","journal-title":"Infect Immun"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1128\/iai.65.6.2396-2401.1997","article-title":"Broad-spectrum antimkicrobial activity of human intestinal defensin 5","volume":"65","author":"Porter EM","year":"1997","unstructured":"Porter EM, Van Dam E, Valore EV, Ganz T. Broad-spectrum antimkicrobial activity of human intestinal defensin 5. Infect Immun. 1997;65:2396\u2013401.","journal-title":"Infect Immun"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/ni797","article-title":"Paneth cell trypsin is an enzyme that regulates human defensin-5","volume":"3","author":"Ghosh D","year":"2002","unstructured":"Ghosh D, Porter E, Shen B, Lee SK, Wilk D, Drazba J, Yadav SP, Crabb JW, Ganz T, Bevins CL. Paneth cell trypsin is an enzyme that regulates human defensin-5. Nat Immunol. 2002;3:583\u201390. 10.1038\/ni797.","journal-title":"Nat Immunol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.peptides.2005.08.018","article-title":"Recent advances in the research and development of human defensins","volume":"27","author":"Chen H","year":"2006","unstructured":"Chen H, Xu Z, Peng L, Fang X, Yin X, Xu N, Cen P. Recent advances in the research and development of human defensins. Peptides. 2006;27:931\u201340.","journal-title":"Peptides"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1172\/JCI112120","article-title":"Defensins: natural peptide antibiotics of human neutrophils","volume":"76","author":"Ganz T","year":"1985","unstructured":"Ganz T, Selsted ME, Szklarek, Harwig SS, Daher K, Bainton DF. Defensins: natural peptide antibiotics of human neutrophils. J Clin Invest. 1985;76:1427\u201335.","journal-title":"J Clin Invest"},{"year":"2022","author":"M'Koma AE","key":"ref24","unstructured":"M'Koma AE. Methods for Diagnosing and Treating Inflammatory Bowel Disease. 2018.01, U.S. Patent No. 11427852B2, 2022."},{"issue":"259","key":"ref25","article-title":"Targeted HD5 Antibody and Assay Methods for Diagnosing and Treating Inflammatory Bowel Disease","volume":"16\/622","author":"M'Koma AE","year":"2021","unstructured":"M'Koma AE, Sakwe AM. Targeted HD5 Antibody and Assay Methods for Diagnosing and Treating Inflammatory Bowel Disease. US Patent App 16\/622,259, 2021.","journal-title":"US Patent App"},{"issue":"11","key":"ref26","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1136\/gut.2003.032805","article-title":"NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression","volume":"53","author":"Wehkamp J","year":"2004","unstructured":"Wehkamp J, Harder J, Weichenthal M, Schwab M, Schaffeler E, Schlee M, Herrlinger KR, Stallmach A, Noack F, Fritz P, Schroder JM, Bevins CL, Fellermann K, Stange EF. NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression. Gut. 2004;53(11):1658\u201364.","journal-title":"Gut"},{"issue":"50","key":"ref27","doi-asserted-by":"crossref","first-page":"18129","DOI":"10.1073\/pnas.0505256102","article-title":"Bevins C L.Reduced Paneth cell alpha- defensins in ileal Crohn's disease","volume":"102","author":"Wehkamp J","year":"2005","unstructured":"Wehkamp J, Salzman NH, Porter E, Nuding S, Weichenthal M, Petras RE, Shen B, Schaeffeler E, Schwab M, Linzmeier R, Feathers RW, Chu H, Lima H Jr, Fellermann K, Ganz T, Stange EF. Bevins C L.Reduced Paneth cell alpha- defensins in ileal Crohn's disease. Proc Natl Acad Sci U S A. 2005;102(50):18129\u201334.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"22","key":"ref28","doi-asserted-by":"crossref","first-page":"5344","DOI":"10.1016\/j.febslet.2006.08.083","article-title":"Paneth cell antimicrobial peptides: topographical distribution and quantification in human gastrointestinal tissues","volume":"580","author":"Wehkamp J","year":"2006","unstructured":"Wehkamp J, Chu H, Shen B, Feathers RW, Kays RJ, Lee SK, Bevins CL. Paneth cell antimicrobial peptides: topographical distribution and quantification in human gastrointestinal tissues. FEBS Lett. 2006;580(22):5344\u201350.","journal-title":"FEBS Lett"},{"issue":"5","key":"ref29","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.4049\/jimmunol.179.5.3109","article-title":"The Paneth cell alpha-defensin deficiency in ileal Crohn's is linked to Wnt\/Tcf-4 signaling","volume":"179","author":"Wehkamp J","year":"2007","unstructured":"Wehkamp J, Wang G, Kubler I, Nuding S, Gregorieff A, Schnabel A, Kays RJ, Fellermann K, Burk O, Schwab M, Clevers H, Bevins CL, Stange EF. The Paneth cell alpha-defensin deficiency in ileal Crohn's is linked to Wnt\/Tcf-4 signaling. J Immunol. 2007;179(5):3109\u201318.","journal-title":"J Immunol"},{"first-page":"197","author":"Bordeaux J","key":"ref30","unstructured":"Bordeaux J, Welsh AW, Agarwal S, Killiam E, Maria T, Hanna JA, Anagnostou VK, Rimm DL, Mar. 48 (3): 197\u2013209."},{"issue":"7","key":"ref31","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1016\/j.jprot.2012.01.030","article-title":"Systematic validation of antibody binding and protein subcellular localization using siRNA and confocal microscopy","volume":"3","author":"Stadler C","unstructured":"Stadler C, Hjelmare M, Neumann B, Jonasson K, Pepperkok R, Uhl\u00e9n M, Lundberg E. Systematic validation of antibody binding and protein subcellular localization using siRNA and confocal microscopy. J Proteom 2012; Apr 3: 75(7):2236\u201351. 10.1016\/j.jprot.2012.01.030. Epub 2012 Feb 15.","journal-title":"J Proteom 2012; Apr"},{"key":"ref32","first-page":"308","article-title":"siRNA knockdown validation 101: Incorporating negative controls in antibody research. F1000Res","volume":"5","author":"Olds W","year":"2016","unstructured":"Olds W, Li J. siRNA knockdown validation 101: Incorporating negative controls in antibody research. F1000Res. 2016; 5: 308."},{"issue":"7","key":"ref33","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.tibtech.2016.03.007","article-title":"Fine-Tuning Next-Generation Genome Editing Tools","volume":"34","author":"Nagamangala C","year":"2016","unstructured":"Nagamangala C, Kanchiswamy, Maffei M, Malnoy M, Velasco R, Kim J. Fine-Tuning Next-Generation Genome Editing Tools. Trends Biotechnol. Jul; 2016;34(7):562\u201374. 10.1016\/j.tibtech.2016.03.007.","journal-title":"Trends Biotechnol"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-4843765\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-4843765\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T16:07:38Z","timestamp":1738598858000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-4843765\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,29]]},"references-count":33,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-4843765\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1007\/s00011-024-01970-w","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2024,8,29]]},"subtype":"preprint"}}